Friday, February 2 2018 | 00 h 00 min | News
Optik has obtained a statement from Essilor Canada responding to the ruling of the Ontario Superior Court in favour of the joint application by the...
Read More
Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)
Learn More
The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.
Read more
SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.
Read more
Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.
Read more Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.
Read more
Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)
Learn More The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.
Read More SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.
Read More Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.
Read More Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.
Read More
Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)
Learn More The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.
Read more SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.
Read more Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.
Read more Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.
Read more Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)
Learn More The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.
Read more SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.
Read more Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.
Read more Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.
Read more
